Bottom price Rivaroxaban - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore
Bottom price Rivaroxaban - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 100kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Tofacitinib, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofacitinib citrate is used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate.
Tofacitinib citrate is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs.
Specification (in house)
Item |
Specification |
Appearance |
White or off-white crystalline powder |
Identification |
IR, HPLC |
Water |
≤1.5% |
Related Substances |
TOFA 06 ≤0.15% |
Tofacitinib trans isomer ≤0.15% |
|
Tofacitinib dehydrogenated ≤0.15% |
|
Each unknown impurity ≤0.10% |
|
Total Impurities: ≤1.0% |
|
Residual Solvents |
Ethanol ≤5000ppm |
Benzene ≤2ppm |
|
Toluene ≤890ppm |
|
Chlroroethane ≤1000ppm |
|
N,N-Dimethylformamide ≤800ppm |
|
Palladium ≤10ppm |
|
Dichloromethane ≤600ppm |
|
Sulphated ash |
≤0.1% |
Heavy Metal |
≤10ppm |
Chrial HPLC |
3S, 4S tofacitinib ≤0.15% |
Assay (on anhydrous basis) 98.0-102.0% |
Product detail pictures:
Related Product Guide:
Well-run equipment, expert income workforce, and far better after-sales expert services; We are also a unified large family, anyone stick to the corporate value "unification, dedication, tolerance" for Bottom price Rivaroxaban - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore , The product will supply to all over the world, such as: Ecuador, Argentina, Hungary, Look forward to the future, we'll focus more on the brand building and promotion . And in the process of our brand global strategic layout we welcome more and more partners join us, work together with us based on mutual benefit. Let's develop market by fully utilizing our in depth advantages and strive for building.
By Naomi from UK - 2018.09.23 18:44
We are long-term partners, there is no disappointment every time, we hope to maintain this friendship later!
By Page from Kyrgyzstan - 2018.09.21 11:01